The introduction of nicotinamide like a nicotine alternative in e-cigarette and smokeless merchandise represents a major regulatory challenge for the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is understood to act as a sedative at superior dosages6. The promises made by Nicotine River, ECBlend, and other sellers that their